FDA greenlights Life Biosciences’ gene therapy study to rewind the age of cellsnews2026-01-27T13:00:47+00:00January 27th, 2026|Endpoints News|
Sarepta touts three-year Duchenne gene therapy data after patient deathsnews2026-01-26T16:17:47+00:00January 26th, 2026|Endpoints News|
ImmunityBio’s cell therapy posts encouraging early data in rare blood cancernews2026-01-16T16:05:02+00:00January 16th, 2026|Endpoints News|
Ocugen touts Phase 2 data for eye disease gene therapynews2026-01-15T13:15:39+00:00January 15th, 2026|Endpoints News|
Scribe Therapeutics plans to test cholesterol-lowering therapy this summernews2026-01-14T21:11:18+00:00January 14th, 2026|Endpoints News|
Nvidia-partnered startup reveals AI-generated enzymes for precise gene insertionnews2026-01-12T21:18:10+00:00January 12th, 2026|Endpoints News|
FDA shares eased manufacturing rules for cell and gene therapiesnews2026-01-12T18:04:55+00:00January 12th, 2026|Endpoints News|
Krystal Biotech says it can deliver native protein to cystic fibrosis patientsnews2026-01-09T15:26:44+00:00January 9th, 2026|Endpoints News|
Medipost gets $140M to take Korean stem cell therapy into USnews2026-01-09T11:30:58+00:00January 9th, 2026|Endpoints News|
Gene editing pioneers launch first startup focused on custom CRISPR therapiesnews2026-01-09T11:00:27+00:00January 9th, 2026|Endpoints News|
